CD4- and CD3-T Lymphocyte Reference Values of Immunocompetent Urban and Rural Subjects in an African Nation

Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the ref...

Full description

Saved in:
Bibliographic Details
Published inScandinavian journal of immunology Vol. 76; no. 1; pp. 33 - 38
Main Authors Adoga, M. P., Pennap, G. R., John, P. A., Shawulu, P. T., Kaba, S. V., Forbi, J. C., Agwale, S. M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2012
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0300-9475
1365-3083
1365-3083
DOI10.1111/j.1365-3083.2012.02700.x

Cover

Loading…
Abstract Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the reference values of CD4 and CD3 T cells in urban and rural Nigerians who were human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. After ethical clearance and informed consent, 1123 subjects who met the inclusion criteria [mean age = 24.4 (± 11.2) years] were recruited in this study. Blood samples were analysed using the BD FACScount cytometer according to the manufacturer’s instructions. Of the overall 1123 subjects, reference means of CD4, CD3 and CD4/CD3 ratio were 1030 ± 367, 1757 ± 609 cells/μl and 0.59 ± 0.08, respectively. Five hundred and fifty‐one (49.1%) were an urban population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1032 ± 369, 1761 ± 612 cells/μl and 0.59 (±0.08), respectively. The remaining 572 (50.9%) were of a rural population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1028 ± 459, 1753 ± 958 cells/μl and 0.59 ± 0.13, respectively. Subjects with higher CD4 and CD3 T cells were more likely to be female than male (P < 0.05). There was no significant difference between the T cell values of the two populations (P > 0.05). Our findings provide new insight in the CD4 and CD3 T cell reference values of Nigerians.
AbstractList Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the reference values of CD4 and CD3 T cells in urban and rural Nigerians who were human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. After ethical clearance and informed consent, 1123 subjects who met the inclusion criteria [mean age = 24.4 (± 11.2) years] were recruited in this study. Blood samples were analysed using the BD FACScount cytometer according to the manufacturer's instructions. Of the overall 1123 subjects, reference means of CD4, CD3 and CD4/CD3 ratio were 1030 ± 367, 1757 ± 609 cells/μl and 0.59 ± 0.08, respectively. Five hundred and fifty-one (49.1%) were an urban population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1032 ± 369, 1761 ± 612 cells/μl and 0.59 (±0.08), respectively. The remaining 572 (50.9%) were of a rural population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1028 ± 459, 1753 ± 958 cells/μl and 0.59 ± 0.13, respectively. Subjects with higher CD4 and CD3 T cells were more likely to be female than male (P < 0.05). There was no significant difference between the T cell values of the two populations (P > 0.05). Our findings provide new insight in the CD4 and CD3 T cell reference values of Nigerians.Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the reference values of CD4 and CD3 T cells in urban and rural Nigerians who were human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. After ethical clearance and informed consent, 1123 subjects who met the inclusion criteria [mean age = 24.4 (± 11.2) years] were recruited in this study. Blood samples were analysed using the BD FACScount cytometer according to the manufacturer's instructions. Of the overall 1123 subjects, reference means of CD4, CD3 and CD4/CD3 ratio were 1030 ± 367, 1757 ± 609 cells/μl and 0.59 ± 0.08, respectively. Five hundred and fifty-one (49.1%) were an urban population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1032 ± 369, 1761 ± 612 cells/μl and 0.59 (±0.08), respectively. The remaining 572 (50.9%) were of a rural population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1028 ± 459, 1753 ± 958 cells/μl and 0.59 ± 0.13, respectively. Subjects with higher CD4 and CD3 T cells were more likely to be female than male (P < 0.05). There was no significant difference between the T cell values of the two populations (P > 0.05). Our findings provide new insight in the CD4 and CD3 T cell reference values of Nigerians.
Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the reference values of CD4 and CD3 T cells in urban and rural Nigerians who were human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. After ethical clearance and informed consent, 1123 subjects who met the inclusion criteria [mean age = 24.4 (± 11.2) years] were recruited in this study. Blood samples were analysed using the BD FACScount cytometer according to the manufacturer's instructions. Of the overall 1123 subjects, reference means of CD4, CD3 and CD4/CD3 ratio were 1030 ± 367, 1757 ± 609 cells/μl and 0.59 ± 0.08, respectively. Five hundred and fifty-one (49.1%) were an urban population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1032 ± 369, 1761 ± 612 cells/μl and 0.59 (±0.08), respectively. The remaining 572 (50.9%) were of a rural population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1028 ± 459, 1753 ± 958 cells/μl and 0.59 ± 0.13, respectively. Subjects with higher CD4 and CD3 T cells were more likely to be female than male (P < 0.05). There was no significant difference between the T cell values of the two populations (P > 0.05). Our findings provide new insight in the CD4 and CD3 T cell reference values of Nigerians.
Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the reference values of CD4 and CD3 T cells in urban and rural Nigerians who were human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. After ethical clearance and informed consent, 1123 subjects who met the inclusion criteria [mean age = 24.4 (± 11.2) years] were recruited in this study. Blood samples were analysed using the BD FACScount cytometer according to the manufacturer’s instructions. Of the overall 1123 subjects, reference means of CD4, CD3 and CD4/CD3 ratio were 1030 ± 367, 1757 ± 609 cells/μl and 0.59 ± 0.08, respectively. Five hundred and fifty‐one (49.1%) were an urban population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1032 ± 369, 1761 ± 612 cells/μl and 0.59 (±0.08), respectively. The remaining 572 (50.9%) were of a rural population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1028 ± 459, 1753 ± 958 cells/μl and 0.59 ± 0.13, respectively. Subjects with higher CD4 and CD3 T cells were more likely to be female than male ( P  < 0.05). There was no significant difference between the T cell values of the two populations ( P  > 0.05). Our findings provide new insight in the CD4 and CD3 T cell reference values of Nigerians.
Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these immunological markers in the initiation of combination antiretroviral therapy (cART). The aim of the present study was to determine and compare the reference values of CD4 and CD3 T cells in urban and rural Nigerians who were human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. After ethical clearance and informed consent, 1123 subjects who met the inclusion criteria [mean age = 24.4 (± 11.2) years] were recruited in this study. Blood samples were analysed using the BD FACScount cytometer according to the manufacturer's instructions. Of the overall 1123 subjects, reference means of CD4, CD3 and CD4/CD3 ratio were 1030 ± 367, 1757 ± 609 cells/µl and 0.59 ± 0.08, respectively. Five hundred and fifty-one (49.1%) were an urban population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1032 ± 369, 1761 ± 612 cells/µl and 0.59 (±0.08), respectively. The remaining 572 (50.9%) were of a rural population with the mean CD4, CD3 and CD4/CD3 T cell ratio of 1028 ± 459, 1753 ± 958 cells/µl and 0.59 ± 0.13, respectively. Subjects with higher CD4 and CD3 T cells were more likely to be female than male (P < 0.05). There was no significant difference between the T cell values of the two populations (P > 0.05). Our findings provide new insight in the CD4 and CD3 T cell reference values of Nigerians. [PUBLICATION ABSTRACT]
Author Adoga, M. P.
Shawulu, P. T.
Agwale, S. M.
Pennap, G. R.
Forbi, J. C.
Kaba, S. V.
John, P. A.
Author_xml – sequence: 1
  givenname: M. P.
  surname: Adoga
  fullname: Adoga, M. P.
  organization: Microbiology Unit, Department of Biological Sciences, Nasarawa State University, Keffi, Nigeria
– sequence: 2
  givenname: G. R.
  surname: Pennap
  fullname: Pennap, G. R.
  organization: Microbiology Unit, Department of Biological Sciences, Nasarawa State University, Keffi, Nigeria
– sequence: 3
  givenname: P. A.
  surname: John
  fullname: John, P. A.
  organization: Microbiology Unit, Department of Biological Sciences, Nasarawa State University, Keffi, Nigeria
– sequence: 4
  givenname: P. T.
  surname: Shawulu
  fullname: Shawulu, P. T.
  organization: Microbiology Unit, Department of Biological Sciences, Nasarawa State University, Keffi, Nigeria
– sequence: 5
  givenname: S. V.
  surname: Kaba
  fullname: Kaba, S. V.
  organization: Federal Polytechnic, Mubi, Adamawa State, Nigeria
– sequence: 6
  givenname: J. C.
  surname: Forbi
  fullname: Forbi, J. C.
  organization: Virology and Immunology Department, Innovative Biotech, Keffi, Nasarawa State, Nigeria
– sequence: 7
  givenname: S. M.
  surname: Agwale
  fullname: Agwale, S. M.
  organization: Virology and Immunology Department, Innovative Biotech, Keffi, Nasarawa State, Nigeria
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22686509$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1v1DAQhi1URLeFv4AsceGS1B9JnBxAqlLYLloV0Q84Wo4zFkkTZ7ETsfvv6-y2PfRUX8Yav8_MeN4TdGQHCwhhSmIazlkbU56lESc5jxmhLCZMEBJv36DF88MRWhBOSFQkIj1GJ963hFDOBH-HjhnL8iwlxQLdlxdJhJWtcXnBo1u83vWbv4PejYCvwYADqwH_Vt0EHg8Gr_p-soMe-g2MYEd85ypl9_j15FSHb6aqBT163MxZfG5co0O8UmMz2PforVGdhw-P8RTdff92W15G65_LVXm-jnSSpySiBa8Yo6IyUIuKJ4QxTTlheUoLQZnOVW0Eq5ShugaSgK6yHIpKaCGoTo3hp-jzoe7GDf_C4KPsG6-h65SFYfKSkrCzPM8yEaSfXkjbYXI2TCdpwhkjJKMkqD4-qqaqh1puXNMrt5NPawyCrweBdoP3DozUzbj_8-hU04WOcvZNtnK2R872yNk3ufdNbkOB_EWBpx6vQL8c0P9NB7tXc_Lmx2q-BT468I0fYfvMK3cvw4JEKv9cLeVluRRpmq3lL_4A0Vy7hg
CitedBy_id crossref_primary_10_1038_s41598_022_12248_8
crossref_primary_10_1371_journal_pgph_0000783
crossref_primary_10_3390_ani14202957
crossref_primary_10_3389_fimmu_2021_721289
crossref_primary_10_1186_s12865_021_00474_0
crossref_primary_10_1016_j_ijid_2013_08_001
crossref_primary_10_1371_journal_pone_0070126
Cites_doi 10.1258/0956462961917825
10.1016/j.jneuroim.2011.02.001
10.3855/jidc.1015
10.1186/1471-2334-9-1
10.1258/td.2011.110219
10.1128/CVI.00378-08
10.4314/thrb.v11i3.47701
10.1111/j.1365-3083.2010.02474.x
10.1016/S0140-6736(11)60247-X
10.1371/journal.pone.0011434
10.1371/journal.pmed.0020214
10.1128/CVI.00044-07
10.1128/CDLI.11.1.29-34.2004
10.1371/journal.pone.0021040
10.1016/j.ijgo.2009.03.057
10.1128/cdli.2.2.233-235.1995
10.1111/j.1365-2567.2010.03260.x
10.4103/1117-1936.172012
10.1002/cyto.b.10011
10.1155/1998/153450
10.1089/vim.2006.19.260
10.1371/journal.pone.0018726
10.1097/00042560-199701010-00016
10.1128/CDLI.6.3.410-414.1999
10.1111/j.1365-2249.2007.03573.x
10.1128/CVI.00483-10
10.1371/journal.pone.0003327
10.1097/00042560-199802010-00017
10.1155/2010/474380
10.1111/j.1365-3083.2011.02558.x
ContentType Journal Article
Copyright 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd
2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.
Copyright_xml – notice: 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd
– notice: 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7U9
8FD
FR3
H94
K9.
M7N
NAPCQ
P64
7X8
DOI 10.1111/j.1365-3083.2012.02700.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Technology Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef
Nursing & Allied Health Premium

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1365-3083
EndPage 38
ExternalDocumentID 3071025131
22686509
10_1111_j_1365_3083_2012_02700_x
SJI2700
ark_67375_WNG_HCG7556L_Q
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1OB
1OC
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
Y6R
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7U9
8FD
FR3
H94
K9.
M7N
NAPCQ
P64
7X8
ID FETCH-LOGICAL-c4850-193b2217bfed7b34022c13028519712c8adf72baf1cde04ecb68e9b7c771c5ff3
IEDL.DBID DR2
ISSN 0300-9475
1365-3083
IngestDate Thu Jul 10 23:24:01 EDT 2025
Fri Jul 25 10:50:04 EDT 2025
Mon Jul 21 06:01:01 EDT 2025
Tue Jul 01 03:56:52 EDT 2025
Thu Apr 24 23:01:02 EDT 2025
Wed Jan 22 16:41:12 EST 2025
Wed Oct 30 09:52:27 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4850-193b2217bfed7b34022c13028519712c8adf72baf1cde04ecb68e9b7c771c5ff3
Notes istex:0ED5A45A04ABEAAB8E0346956E2FC11EB031B411
ArticleID:SJI2700
ark:/67375/WNG-HCG7556L-Q
ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-3083.2012.02700.x
PMID 22686509
PQID 1432200610
PQPubID 37516
PageCount 6
ParticipantIDs proquest_miscellaneous_1020188667
proquest_journals_1432200610
pubmed_primary_22686509
crossref_citationtrail_10_1111_j_1365_3083_2012_02700_x
crossref_primary_10_1111_j_1365_3083_2012_02700_x
wiley_primary_10_1111_j_1365_3083_2012_02700_x_SJI2700
istex_primary_ark_67375_WNG_HCG7556L_Q
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-07
July 2012
2012-07-00
2012-Jul
20120701
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 07
  year: 2012
  text: 2012-07
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Oxford
PublicationTitle Scandinavian journal of immunology
PublicationTitleAlternate Scand J Immunol
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Aina O, Dadik J, Charurat M et al. Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol 2005;12:525-30.
Menard D, Mandeng MJ, Tothy MB et al. Immunohematological reference ranges for adults from the Central African Republic. Clin Diagn Lab Immunol 2003;10:443-5.
Lugada ES, Mermin J, Kaharuza F et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol 2004;11:29-4.
Forbi JC, Forbi TD, Agwale SM. Estimating the time period between infection and diagnosis based on CD4 +  counts at first diagnosis among HIV-1 antiretroviral naïve patients in Nigeria. J Infect Dev Ctries 2010;4:662-7.
Forbi JC, Agwale SM. Inverted CD4 + /CD8 +  ratio associated with AIDS event and death in HIV-1 infected individuals in Nasarawa State, Nigeria. Tanzan J Health Res 2009;11:144-8.
Mair C, Hawes SE, Agne HD et al. Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals. Clin Exp Immunol 2008;151:432-40.
Jiang W, Kang L, Lu H et al. Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai. Clin Diagn Lab Immunol 2004;11:811-3.
Namazi MR. The Th1-promoting effects of dehydroepiandrosterone can provide an explanation for the stronger Th1 immune response of women. Iran J Allergy Asthma Immunol 2009;8:65-9.
Domagala-Kulawik J, Hoser G, Dabrowska M, Safianowska A, Chazan R. CD4 + /CD25 +  cells in systemic inflammation in COPD. Scand J Immunol 2011;73:59-5.
Hirnschall G, Schwartlander B. Treatment 2.0: catalysing the next phase of scale-up. Lancet (in press) 2011;378:209-11.
Tsegaye A, Messele T, Tilahun T et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999;6:410-4.
Tugume SB, Piwowar EM, Lutalo T et al. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 1995;2:233-5.
Boufassa F, Saez-Cirion A, Lechenadec J et al. CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory. PLoS ONE 2011;6:e18726.
Abimiku A, Villalba-Diebold P, Dadik J, Okolo F, Mang E, Charurat M. Risk factors associated with low CD4 +  lymphocyte count among HIV-positive pregnant women in Nigeria. Int J Gynaecol Obstet 2009;106:227-31.
Ampofo W, Torpey K, Mukadi YD et al. Normal CD4 +  T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern Region of Ghana. Viral Immunol 2006;19:260-6.
Nwokedi EE, Ochicha O, Mohammed AZ, Saddiq NM. Baseline CD4 lymphocyte count among HIV patients in Kano, Northern Nigeria. Afr J Health Sci 2007;14:212-5.
Corthay A, Lorvik KB, Bogen B. Is secretion of tumor-specific antigen important for cancer eradication by CD4 +  T cells? - Implications for cancer immunotherapy by adoptive T cell transfer. Scand J Immunol 2011;73:527-30.
McKinnon LR, Kimani M, Wachihi C et al. Effect of baseline HIV disease parameters on CD4 +  T cell recovery after antiretroviral therapy initiation in Kenyan Women. PLoS ONE 2010;5:e11434.
Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Infect Dis 2009;9:1-7.
Bentwich Z. CD4 measurements in patients with HIV: are they feasible for poor settings? PLoS Med 2005;2:e214.
Kalinkovich A, Weisman Z, Burstein R, Bentwich Z. Standard values of T-lymphocyte subsets in Africa. J Acquir Immune Defic Syndr 1998;17:183-4.
Zeh C, Amornkul PN, Inzaule S et al. Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. PLoS ONE 2011;6:e21040.
Oladepo DK, Idigbe EO, Audu RA et al. Establishment of reference values of CD4 and CD8 lymphocyte subsets in healthy Nigerian adults. Clin Vaccine Immunol 2009;16:1374-7.
Biegler BW, Yan SX, Ortega SB, Tennakoon DK, Racke MK, Karandikar NJ. Clonal composition of neuroantigen-specific CD8 +  and CD4 +  T cells in multiple sclerosis. J Neuroimmunol 2011;234:131-40.
Feki S, Rekaya Z, Chaaben TB et al. Determination of T-lymphocyte Subsets in a North African population (Tunisia): establishment of normal ranges and results in HIV-infected individuals. Dis Markers 1998;14:161-4.
Sagnia B, Ateba Ndongo F, Ndiang Moyo Tetang S et al. Reference values of lymphocyte subsets in healthy HIV negative children in Cameroon. Clin Vaccine Immunol 2011;18:790-95.
MacLeod MKL, Kappler JW, Marrack P. Memory CD4 T cells: generation, reactivation and re-assignment. J Immunol 2010;130:10-5.
Bussmann H, Webster CW, Masupu KV et al. Low CD4 +  T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol 2004;11:930-5.
Uppal SS, Shashi V, Dhot PS. Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry B Clin Cytom 2003;52:32-6.
Njoku MO, Sirisena ND, Idoko JA, Jelpe D. CD4 +  T-lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV-1) and healthy population in Jos, Nigeria. Niger Postgrad Med J 2003;10:135-9.
Idigbe EO, Audu RA, Iroha EO et al. T-lymphocyte subsets in apparently healthy Nigerian children. Int J Pediatr 2010;2010:1-7.
Klose N, Coulibaly B, Tebit DM et al. Immunohematological reference values for healthy adults in Burkina Faso. Clin Vaccine Immunol 2007;14:782-4.
Kibaya RS, Bautista CT, Sawe FK et al. Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya. PLoS ONE 2008;3:e3327.
Zekeng L, Sadjo A, Meli J et al. T lymphocyte subset values among healthy Cameroonians. J Acquir Immune Defic Syndr 1997;14:82-3.
Levin A, Brubaker G, Shao JS et al. Determination of T- lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int J STD AIDS 1996;7:288-91.
Pennap GR, Adoga MP, Forbi JC, Ojobo F, Agwale SM. CD4 T lymphocyte reference values of immunocompetent subjects in an African University. Trop Doct 2011;41:218-21.
2011; 378
2011; 234
2010; 2010
2006; 19
2008; 3
1995; 2
2011; 6
1999; 6
2003; 52
2011; 18
2007; 14
2003; 10
2004; 11
2009; 11
1998; 17
1997; 14
2011; 73
2011; 41
2010; 130
2009; 9
2009; 8
2005; 2
2010; 5
2010; 4
2009; 16
2005; 12
2008; 151
1998; 14
2009; 106
1996; 7
e_1_2_6_31_2
e_1_2_6_18_2
Bussmann H (e_1_2_6_4_2) 2004; 11
e_1_2_6_12_2
e_1_2_6_13_2
e_1_2_6_34_2
e_1_2_6_10_2
e_1_2_6_11_2
e_1_2_6_32_2
e_1_2_6_16_2
e_1_2_6_39_2
e_1_2_6_17_2
e_1_2_6_38_2
e_1_2_6_14_2
e_1_2_6_37_2
e_1_2_6_15_2
e_1_2_6_36_2
e_1_2_6_20_2
Tugume SB (e_1_2_6_41_2) 1995; 2
e_1_2_6_40_2
Jiang W (e_1_2_6_19_2) 2004; 11
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_29_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
Njoku MO (e_1_2_6_30_2) 2003; 10
Aina O (e_1_2_6_9_2) 2005; 12
e_1_2_6_23_2
Namazi MR (e_1_2_6_33_2) 2009; 8
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
Menard D (e_1_2_6_35_2) 2003; 10
e_1_2_6_26_2
Nwokedi EE (e_1_2_6_24_2) 2007; 14
e_1_2_6_25_2
References_xml – reference: Bentwich Z. CD4 measurements in patients with HIV: are they feasible for poor settings? PLoS Med 2005;2:e214.
– reference: Forbi JC, Forbi TD, Agwale SM. Estimating the time period between infection and diagnosis based on CD4 +  counts at first diagnosis among HIV-1 antiretroviral naïve patients in Nigeria. J Infect Dev Ctries 2010;4:662-7.
– reference: Zeh C, Amornkul PN, Inzaule S et al. Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. PLoS ONE 2011;6:e21040.
– reference: Pennap GR, Adoga MP, Forbi JC, Ojobo F, Agwale SM. CD4 T lymphocyte reference values of immunocompetent subjects in an African University. Trop Doct 2011;41:218-21.
– reference: Biegler BW, Yan SX, Ortega SB, Tennakoon DK, Racke MK, Karandikar NJ. Clonal composition of neuroantigen-specific CD8 +  and CD4 +  T cells in multiple sclerosis. J Neuroimmunol 2011;234:131-40.
– reference: Domagala-Kulawik J, Hoser G, Dabrowska M, Safianowska A, Chazan R. CD4 + /CD25 +  cells in systemic inflammation in COPD. Scand J Immunol 2011;73:59-5.
– reference: MacLeod MKL, Kappler JW, Marrack P. Memory CD4 T cells: generation, reactivation and re-assignment. J Immunol 2010;130:10-5.
– reference: Ampofo W, Torpey K, Mukadi YD et al. Normal CD4 +  T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern Region of Ghana. Viral Immunol 2006;19:260-6.
– reference: McKinnon LR, Kimani M, Wachihi C et al. Effect of baseline HIV disease parameters on CD4 +  T cell recovery after antiretroviral therapy initiation in Kenyan Women. PLoS ONE 2010;5:e11434.
– reference: Tsegaye A, Messele T, Tilahun T et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999;6:410-4.
– reference: Hirnschall G, Schwartlander B. Treatment 2.0: catalysing the next phase of scale-up. Lancet (in press) 2011;378:209-11.
– reference: Zekeng L, Sadjo A, Meli J et al. T lymphocyte subset values among healthy Cameroonians. J Acquir Immune Defic Syndr 1997;14:82-3.
– reference: Corthay A, Lorvik KB, Bogen B. Is secretion of tumor-specific antigen important for cancer eradication by CD4 +  T cells? - Implications for cancer immunotherapy by adoptive T cell transfer. Scand J Immunol 2011;73:527-30.
– reference: Klose N, Coulibaly B, Tebit DM et al. Immunohematological reference values for healthy adults in Burkina Faso. Clin Vaccine Immunol 2007;14:782-4.
– reference: Forbi JC, Agwale SM. Inverted CD4 + /CD8 +  ratio associated with AIDS event and death in HIV-1 infected individuals in Nasarawa State, Nigeria. Tanzan J Health Res 2009;11:144-8.
– reference: Tugume SB, Piwowar EM, Lutalo T et al. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 1995;2:233-5.
– reference: Aina O, Dadik J, Charurat M et al. Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol 2005;12:525-30.
– reference: Kibaya RS, Bautista CT, Sawe FK et al. Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya. PLoS ONE 2008;3:e3327.
– reference: Uppal SS, Shashi V, Dhot PS. Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry B Clin Cytom 2003;52:32-6.
– reference: Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Infect Dis 2009;9:1-7.
– reference: Bussmann H, Webster CW, Masupu KV et al. Low CD4 +  T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol 2004;11:930-5.
– reference: Lugada ES, Mermin J, Kaharuza F et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol 2004;11:29-4.
– reference: Boufassa F, Saez-Cirion A, Lechenadec J et al. CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory. PLoS ONE 2011;6:e18726.
– reference: Mair C, Hawes SE, Agne HD et al. Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals. Clin Exp Immunol 2008;151:432-40.
– reference: Nwokedi EE, Ochicha O, Mohammed AZ, Saddiq NM. Baseline CD4 lymphocyte count among HIV patients in Kano, Northern Nigeria. Afr J Health Sci 2007;14:212-5.
– reference: Idigbe EO, Audu RA, Iroha EO et al. T-lymphocyte subsets in apparently healthy Nigerian children. Int J Pediatr 2010;2010:1-7.
– reference: Sagnia B, Ateba Ndongo F, Ndiang Moyo Tetang S et al. Reference values of lymphocyte subsets in healthy HIV negative children in Cameroon. Clin Vaccine Immunol 2011;18:790-95.
– reference: Oladepo DK, Idigbe EO, Audu RA et al. Establishment of reference values of CD4 and CD8 lymphocyte subsets in healthy Nigerian adults. Clin Vaccine Immunol 2009;16:1374-7.
– reference: Menard D, Mandeng MJ, Tothy MB et al. Immunohematological reference ranges for adults from the Central African Republic. Clin Diagn Lab Immunol 2003;10:443-5.
– reference: Jiang W, Kang L, Lu H et al. Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai. Clin Diagn Lab Immunol 2004;11:811-3.
– reference: Abimiku A, Villalba-Diebold P, Dadik J, Okolo F, Mang E, Charurat M. Risk factors associated with low CD4 +  lymphocyte count among HIV-positive pregnant women in Nigeria. Int J Gynaecol Obstet 2009;106:227-31.
– reference: Namazi MR. The Th1-promoting effects of dehydroepiandrosterone can provide an explanation for the stronger Th1 immune response of women. Iran J Allergy Asthma Immunol 2009;8:65-9.
– reference: Kalinkovich A, Weisman Z, Burstein R, Bentwich Z. Standard values of T-lymphocyte subsets in Africa. J Acquir Immune Defic Syndr 1998;17:183-4.
– reference: Feki S, Rekaya Z, Chaaben TB et al. Determination of T-lymphocyte Subsets in a North African population (Tunisia): establishment of normal ranges and results in HIV-infected individuals. Dis Markers 1998;14:161-4.
– reference: Njoku MO, Sirisena ND, Idoko JA, Jelpe D. CD4 +  T-lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV-1) and healthy population in Jos, Nigeria. Niger Postgrad Med J 2003;10:135-9.
– reference: Levin A, Brubaker G, Shao JS et al. Determination of T- lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int J STD AIDS 1996;7:288-91.
– volume: 16
  start-page: 1374
  year: 2009
  end-page: 7
  article-title: Establishment of reference values of CD4 and CD8 lymphocyte subsets in healthy Nigerian adults
  publication-title: Clin Vaccine Immunol
– volume: 3
  start-page: e3327
  year: 2008
  article-title: Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya
  publication-title: PLoS ONE
– volume: 11
  start-page: 930
  year: 2004
  end-page: 5
  article-title: Low CD4    T‐lymphocyte values in human immunodeficiency virus‐negative adults in Botswana
  publication-title: Clin Diagn Lab Immunol
– volume: 41
  start-page: 218
  year: 2011
  end-page: 21
  article-title: CD4 T lymphocyte reference values of immunocompetent subjects in an African University
  publication-title: Trop Doct
– volume: 106
  start-page: 227
  year: 2009
  end-page: 31
  article-title: Risk factors associated with low CD4    lymphocyte count among HIV‐positive pregnant women in Nigeria
  publication-title: Int J Gynaecol Obstet
– volume: 10
  start-page: 135
  year: 2003
  end-page: 9
  article-title: CD4    T‐lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV‐1) and healthy population in Jos, Nigeria
  publication-title: Niger Postgrad Med J
– volume: 2
  start-page: e214
  year: 2005
  article-title: CD4 measurements in patients with HIV: are they feasible for poor settings?
  publication-title: PLoS Med
– volume: 5
  start-page: e11434
  year: 2010
  article-title: Effect of baseline HIV disease parameters on CD4 +  T cell recovery after antiretroviral therapy initiation in Kenyan Women
  publication-title: PLoS ONE
– volume: 14
  start-page: 782
  year: 2007
  end-page: 4
  article-title: Immunohematological reference values for healthy adults in Burkina Faso
  publication-title: Clin Vaccine Immunol
– volume: 2
  start-page: 233
  year: 1995
  end-page: 5
  article-title: Hematological reference ranges among healthy Ugandans
  publication-title: Clin Diagn Lab Immunol
– volume: 130
  start-page: 10
  year: 2010
  end-page: 5
  article-title: Memory CD4 T cells: generation, reactivation and re‐assignment
  publication-title: J Immunol
– volume: 12
  start-page: 525
  year: 2005
  end-page: 30
  article-title: Reference values of CD4 T lymphocytes in human immunodeficiency virus‐negative adult Nigerians
  publication-title: Clin Diagn Lab Immunol
– volume: 10
  start-page: 443
  year: 2003
  end-page: 5
  article-title: Immunohematological reference ranges for adults from the Central African Republic
  publication-title: Clin Diagn Lab Immunol
– volume: 8
  start-page: 65
  year: 2009
  end-page: 9
  article-title: The Th1‐promoting effects of dehydroepiandrosterone can provide an explanation for the stronger Th1 immune response of women
  publication-title: Iran J Allergy Asthma Immunol
– volume: 14
  start-page: 82
  year: 1997
  end-page: 3
  article-title: T lymphocyte subset values among healthy Cameroonians
  publication-title: J Acquir Immune Defic Syndr
– volume: 2010
  start-page: 1
  year: 2010
  end-page: 7
  article-title: T‐lymphocyte subsets in apparently healthy Nigerian children
  publication-title: Int J Pediatr
– volume: 7
  start-page: 288
  year: 1996
  end-page: 91
  article-title: Determination of T‐ lymphocyte subsets on site in rural Tanzania: results in HIV‐1 infected and non‐infected individuals
  publication-title: Int J STD AIDS
– volume: 14
  start-page: 161
  year: 1998
  end-page: 4
  article-title: Determination of T‐lymphocyte Subsets in a North African population (Tunisia): establishment of normal ranges and results in HIV‐infected individuals
  publication-title: Dis Markers
– volume: 378
  start-page: 209
  year: 2011
  end-page: 11
  article-title: Treatment 2.0: catalysing the next phase of scale‐up
  publication-title: Lancet
– volume: 4
  start-page: 662
  year: 2010
  end-page: 7
  article-title: Estimating the time period between infection and diagnosis based on CD4    counts at first diagnosis among HIV‐1 antiretroviral naïve patients in Nigeria
  publication-title: J Infect Dev Ctries
– volume: 17
  start-page: 183
  year: 1998
  end-page: 4
  article-title: Standard values of T‐lymphocyte subsets in Africa
  publication-title: J Acquir Immune Defic Syndr
– volume: 73
  start-page: 59
  year: 2011
  end-page: 5
  article-title: CD4 + /CD25 +  cells in systemic inflammation in COPD
  publication-title: Scand J Immunol
– volume: 6
  start-page: e18726
  year: 2011
  article-title: CD4 dynamics over a 15 year‐period among HIV controllers enrolled in the ANRS French observatory
  publication-title: PLoS ONE
– volume: 52
  start-page: 32
  year: 2003
  end-page: 6
  article-title: Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking
  publication-title: Cytometry B Clin Cytom
– volume: 9
  start-page: 1
  year: 2009
  end-page: 7
  article-title: Immunohaematological reference values in human immunodeficiency virus‐negative adolescent and adults in rural northern Tanzania
  publication-title: BMC Infect Dis
– volume: 11
  start-page: 811
  year: 2004
  end-page: 3
  article-title: Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai
  publication-title: Clin Diagn Lab Immunol
– volume: 19
  start-page: 260
  year: 2006
  end-page: 6
  article-title: Normal CD4 +  T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern Region of Ghana
  publication-title: Viral Immunol
– volume: 14
  start-page: 212
  year: 2007
  end-page: 5
  article-title: Baseline CD4 lymphocyte count among HIV patients in Kano, Northern Nigeria
  publication-title: Afr J Health Sci
– volume: 6
  start-page: 410
  year: 1999
  end-page: 4
  article-title: Immunohematological reference ranges for adult Ethiopians
  publication-title: Clin Diagn Lab Immunol
– volume: 18
  start-page: 790
  year: 2011
  end-page: 95
  article-title: Reference values of lymphocyte subsets in healthy HIV negative children in Cameroon
  publication-title: Clin Vaccine Immunol
– volume: 11
  start-page: 29
  year: 2004
  end-page: 4
  article-title: Population‐based hematologic and immunologic reference values for a healthy Ugandan population
  publication-title: Clin Diagn Lab Immunol
– volume: 6
  start-page: e21040
  year: 2011
  article-title: Population‐based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya
  publication-title: PLoS ONE
– volume: 234
  start-page: 131
  year: 2011
  end-page: 40
  article-title: Clonal composition of neuroantigen‐specific CD8    and CD4    T cells in multiple sclerosis
  publication-title: J Neuroimmunol
– volume: 151
  start-page: 432
  year: 2008
  end-page: 40
  article-title: Factors associated with CD4 lymphocyte counts in HIV‐negative Senegalese individuals
  publication-title: Clin Exp Immunol
– volume: 11
  start-page: 144
  year: 2009
  end-page: 8
  article-title: Inverted CD4   /CD8    ratio associated with AIDS event and death in HIV‐1 infected individuals in Nasarawa State, Nigeria
  publication-title: Tanzan J Health Res
– volume: 73
  start-page: 527
  year: 2011
  end-page: 30
  article-title: Is secretion of tumor‐specific antigen important for cancer eradication by CD4    T cells? – Implications for cancer immunotherapy by adoptive T cell transfer
  publication-title: Scand J Immunol
– volume: 11
  start-page: 811
  year: 2004
  ident: e_1_2_6_19_2
  article-title: Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai
  publication-title: Clin Diagn Lab Immunol
– ident: e_1_2_6_39_2
  doi: 10.1258/0956462961917825
– ident: e_1_2_6_8_2
  doi: 10.1016/j.jneuroim.2011.02.001
– ident: e_1_2_6_23_2
  doi: 10.3855/jidc.1015
– ident: e_1_2_6_38_2
  doi: 10.1186/1471-2334-9-1
– ident: e_1_2_6_29_2
  doi: 10.1258/td.2011.110219
– ident: e_1_2_6_25_2
  doi: 10.1128/CVI.00378-08
– ident: e_1_2_6_22_2
  doi: 10.4314/thrb.v11i3.47701
– ident: e_1_2_6_12_2
  doi: 10.1111/j.1365-3083.2010.02474.x
– ident: e_1_2_6_18_2
  doi: 10.1016/S0140-6736(11)60247-X
– ident: e_1_2_6_14_2
  doi: 10.1371/journal.pone.0011434
– ident: e_1_2_6_27_2
  doi: 10.1371/journal.pmed.0020214
– ident: e_1_2_6_2_2
  doi: 10.1128/CVI.00044-07
– ident: e_1_2_6_6_2
  doi: 10.1128/CDLI.11.1.29-34.2004
– volume: 12
  start-page: 525
  year: 2005
  ident: e_1_2_6_9_2
  article-title: Reference values of CD4 T lymphocytes in human immunodeficiency virus‐negative adult Nigerians
  publication-title: Clin Diagn Lab Immunol
– ident: e_1_2_6_5_2
  doi: 10.1371/journal.pone.0021040
– volume: 8
  start-page: 65
  year: 2009
  ident: e_1_2_6_33_2
  article-title: The Th1‐promoting effects of dehydroepiandrosterone can provide an explanation for the stronger Th1 immune response of women
  publication-title: Iran J Allergy Asthma Immunol
– ident: e_1_2_6_16_2
  doi: 10.1016/j.ijgo.2009.03.057
– volume: 2
  start-page: 233
  year: 1995
  ident: e_1_2_6_41_2
  article-title: Hematological reference ranges among healthy Ugandans
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/cdli.2.2.233-235.1995
– ident: e_1_2_6_11_2
  doi: 10.1111/j.1365-2567.2010.03260.x
– ident: e_1_2_6_26_2
– volume: 10
  start-page: 135
  year: 2003
  ident: e_1_2_6_30_2
  article-title: CD4 +  T‐lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV‐1) and healthy population in Jos, Nigeria
  publication-title: Niger Postgrad Med J
  doi: 10.4103/1117-1936.172012
– volume: 10
  start-page: 443
  year: 2003
  ident: e_1_2_6_35_2
  article-title: Immunohematological reference ranges for adults from the Central African Republic
  publication-title: Clin Diagn Lab Immunol
– ident: e_1_2_6_20_2
  doi: 10.1002/cyto.b.10011
– volume: 11
  start-page: 930
  year: 2004
  ident: e_1_2_6_4_2
  article-title: Low CD4 +  T‐lymphocyte values in human immunodeficiency virus‐negative adults in Botswana
  publication-title: Clin Diagn Lab Immunol
– volume: 14
  start-page: 212
  year: 2007
  ident: e_1_2_6_24_2
  article-title: Baseline CD4 lymphocyte count among HIV patients in Kano, Northern Nigeria
  publication-title: Afr J Health Sci
– ident: e_1_2_6_40_2
  doi: 10.1155/1998/153450
– ident: e_1_2_6_21_2
  doi: 10.1089/vim.2006.19.260
– ident: e_1_2_6_15_2
  doi: 10.1371/journal.pone.0018726
– ident: e_1_2_6_34_2
  doi: 10.1097/00042560-199701010-00016
– ident: e_1_2_6_36_2
  doi: 10.1128/CDLI.6.3.410-414.1999
– ident: e_1_2_6_28_2
– ident: e_1_2_6_31_2
  doi: 10.1111/j.1365-2249.2007.03573.x
– ident: e_1_2_6_32_2
  doi: 10.1128/CVI.00483-10
– ident: e_1_2_6_37_2
  doi: 10.1371/journal.pone.0003327
– ident: e_1_2_6_7_2
– ident: e_1_2_6_17_2
– ident: e_1_2_6_3_2
  doi: 10.1097/00042560-199802010-00017
– ident: e_1_2_6_10_2
  doi: 10.1155/2010/474380
– ident: e_1_2_6_13_2
  doi: 10.1111/j.1365-3083.2011.02558.x
SSID ssj0013273
Score 2.0143402
Snippet Studies on the reference values of CD4 and CD3 T cells in healthy individuals have continued to gain significance because of the importance of these...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 33
SubjectTerms Adolescent
Adult
CD3 Complex - blood
CD3 Complex - immunology
CD4 Antigens - blood
CD4 Antigens - immunology
Cross-Sectional Studies
Female
Flow Cytometry
Humans
Leukocytes, Mononuclear
Male
Nigeria
Reference Values
Rural Population
T-Lymphocytes - immunology
Urban Population
Young Adult
Title CD4- and CD3-T Lymphocyte Reference Values of Immunocompetent Urban and Rural Subjects in an African Nation
URI https://api.istex.fr/ark:/67375/WNG-HCG7556L-Q/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-3083.2012.02700.x
https://www.ncbi.nlm.nih.gov/pubmed/22686509
https://www.proquest.com/docview/1432200610
https://www.proquest.com/docview/1020188667
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQEYgLlPIKtMhIiFtWefmRI9rSbqtSidKF3izbsSW0VYJ2s1KXEz-B38gvYSbORl3UQ4W4WXbGiScz9jee8ZiQt3npeFWYJK6E53HBfRmXhpWxKxH9VqV0rovyPeWTaXF8wS76-Cc8CxPyQwwbbqgZ3XyNCq7NYlPJMUIrBwyBEVrZKEEf6gjxJDYgPjrLrjkUgrM5T5K4LATbDOq5saONleouMv3qJhi6iWq7ZengEZmtBxSiUWajZWtG9sdfuR7_z4i3ycMevdL3Qdwekzuu3iH3wn2Wqx1y_2PvqX9CmvF-8fvnL6rrio73cyie05MViE5jV62jQ35b-kVfwkBp4-kRHlVpbA_kWzqdG113HZxhbhAKcxxuGi3oN6yl4YajmobM3k_J9ODD-XgS95c7xLaQLIkBOJoM7CHjXSVMDmZsZtGJKvEkbZpZqSsvMqN9aiuXFM4aLl1phBUitcz7_BnZqpvavSCUgYQZnxsrvCtsBTTClFpDn4Xk0mQREesfqWyf-Rwv4LhU1ywg4KxCzirkrOo4q64ikg6U30P2j1vQvOtkZSDQ8xlGzwmmvp4eqsn4UDDGT9SniOyuhUn1E8cCLDGYYRFXJhF5MzSDyqMfR9euWcIzAPFTKTkXEXkehHB4GaBpiUkRI8I7Ubr1Z6vPx0dYevmvhK_IA6wOocy7ZKudL90eALbWvO5U8Q8C0S6p
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwED-hTfx5GTAYCwwwEuItVf7aziPq2NrRVWK0sDcrdmwJrUpQ10orT3wEPiOfhLskjVa0hwnxFiU-J77c2b_zne8A3saZ5UWiA78QjvsJd5mf6TTzbUbot8iktXWU75gPpsnJeXrelgOiszBNfohuw400o56vScFpQ3pTyylEK0YQQSFaUS8gJ2oPAeU2Ffiu7auz6JpLoXE3x0HgZ4lIN8N6buxpY63aJrZf3QREN3FtvTAdPYTZekhNPMpFb7nQPfPjr2yP_2nMj2CnBbDsfSNxj-GOLXfhblPScrUL905bZ_0TqPqHye-fv1heFqx_GOPlhI1WKD2VWS0s61Lcsi_5DEfKKseGdFqlMi2WX7DpXOdl3cEZpQdhOM3RvtEl-0Z3WVPkqGRNcu-nMD36MOkP_La-g28SmQY-YkcdoUmknS2EjtGSjQz5USUdpg0jI_PCiUjnLjSFDRJrNJc208IIEZrUuXgPtsqqtPvAUhQy7WJthLOJKZBG6CzPsc9EcqkjD8T6TyrTJj-nGhwzdc0IQs4q4qwizqqas-rKg7Cj_N4kALkFzbtaWDqCfH5BAXQiVV_Hx2rQPxZpykfqkwcHa2lS7dxxicYYTrIELQMP3nSPUevJlZOXtlpiG0T5oZScCw-eNVLYvQwBtaS8iB7wWpZu_dnq88mQrp7_K-FruD-YnI7UaDj--AIeUJMmsvkAthbzpX2J-G2hX9V6-QfyQTLE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED-hTUy88DG-AgOMhHhLlQ_Hdh5RS9eOUsFYYW9W7NgS6pRMXSutPPEn8Dfyl-CL02hFe5gQb1Hic-LLnf073_kO4E2aG1ZSFYUltyykzOZhrrI8NDmi3zIXxjRRvlM2mtGj0-y0jX_CszA-P0S34Yaa0czXqODnpd1WcozQSh2GwAitpBehD7Xn8OQuZZFACR8cJ1c8Ct7bnEZRmFOebUf1XNvT1lK1i1y_vA6HbsPaZl0a3oP5ZkQ-HGXeWy1VT__4K9nj_xnyfbjbwlfyzsvbA7hlqn247Qtarvdh72Prqn8IdX9Af__8RYqqJP1B6i5PyGTtZKfW66UhXYJb8rU4cwMltSVjPKtS6xbJL8lsoYqq6eAYk4MQN8nhrtEF-Y53iS9xVBGf2vsRzIbvT_qjsK3uEGoqsih0yFElziBS1pRcpc6OTTR6UQUepY0TLYrS8kQVNtaliajRigmTK645j3VmbfoYdqq6Mk-BZE7ElE2V5tZQXToarvKicH1SwYRKAuCbHyl1m_ocK3CcySsmkOOsRM5K5KxsOCsvA4g7ynOf_uMGNG8bWekIisUcw-d4Jr9ND-Wof8izjE3k5wAONsIk25njwplibopFYBkF8Lp77HQeHTlFZeqVa-MwfiwEYzyAJ14Iu5c5OC0wK2IArBGlG3-2_HI0xqtn_0r4CvY-DYZyMp5-eA53sIUPaz6AneViZV448LZULxut_AM4jjF8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD4-+and+CD3-T+lymphocyte+reference+values+of+immunocompetent+urban+and+rural+subjects+in+an+African+nation&rft.jtitle=Scandinavian+journal+of+immunology&rft.au=Adoga%2C+M+P&rft.au=Pennap%2C+G+R&rft.au=John%2C+P+A&rft.au=Shawulu%2C+P+T&rft.date=2012-07-01&rft.issn=1365-3083&rft.eissn=1365-3083&rft.volume=76&rft.issue=1&rft.spage=33&rft_id=info:doi/10.1111%2Fj.1365-3083.2012.02700.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9475&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9475&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9475&client=summon